Apollomics APLM
NASDAQ APLM
$23.86 -1.02 (-4.04%)
As of: Sep 10, 2026 · 11:04 AM EDT

Apollomics (APLM) Retained Earnings (2021 - 2025)

Apollomics' (APLM) quarterly Retained Earnings came in at -$711.8 million in Q4 2025, down 1.56% year-over-year from -$723.0 million in Q4 2024, and little changed quarter-over-quarter from -$713.4 million in Q2 2025.

Analysis

Apollomics (APLM) Retained Earnings (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Retained Earnings for 5 consecutive years, with -$711.8 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Retained Earnings fell 1.56% year-over-year to -$711.8 million in Q4 2025; TTM through Dec 2025 was -$711.8 million, a 1.56% decrease from a year earlier, with the FY2025 full-year figure at -$711.8 million, down 1.56% from the prior year.
  • Retained Earnings was -$711.8 million for Q4 2025 at Apollomics, roughly flat from -$713.4 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$281672.0 in Q2 2022 and troughed at -$713.4 million in Q2 2025.
  • A 5-year average of -$532.3 million and a median of -$647.0 million in 2023 frame the typical range for Retained Earnings.
  • Across the five-year window, Retained Earnings tumbled 221823.37% in 2023 and retreated 1.56% in 2025, its largest moves.
  • Over 5 years, Retained Earnings stood at -$235.4 million in 2021, then plunged by 101.58% to -$474.6 million in 2022, then slumped by 36.32% to -$647.0 million in 2023, then fell by 8.32% to -$700.8 million in 2024, then slipped by 1.56% to -$711.8 million in 2025.
  • The last three Retained Earnings figures came in at -$711.8 million (Q4 2025), -$713.4 million (Q2 2025), and -$700.8 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 558.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.13 Bn
10 Apollomics 34.50 Mn 31.23 Mn - -711.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -711.76 Mn
Jun 30, 2025 -713.36 Mn
Dec 31, 2024 -700.82 Mn
Jun 30, 2024 -682.17 Mn
Dec 31, 2023 -646.97 Mn
Jun 30, 2023 -625.10 Mn
Dec 31, 2022 -474.60 Mn
Jun 30, 2022 -281,672.00
Dec 31, 2021 -235.44 Mn